METex14del
Showing 1 - 25 of 4,181
Capmatinib vs. Standard of Care for German Adult Locally
Completed
- Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations
-
Berlin, Germany
- +9 more
Mar 22, 2023
Solid Tumor Trial in El Segundo (AMG 337)
Withdrawn
- Solid Tumor
- AMG 337
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Aug 23, 2019
Cannabis Use, Adolescent Behavior, E-health Trial in Sevilla (ALERTA CANNABIS)
Recruiting
- Cannabis Use
- +2 more
- ALERTA CANNABIS
-
Sevilla, SpainUniversity of Sevilla
Apr 27, 2023
Tabrecta® (Capmatinib) in South Korea
Not yet recruiting
- Non-Small-Cell Lung Carcinoma
- Capmatinib
- (no location specified)
Jan 19, 2023
Advanced (Stage IIIB/IV) NSCLC (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Trial in Worldwide
Active, not recruiting
- Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
-
Duarte, California
- +140 more
Jun 7, 2022
Disease Specific Pathways and Modifiers in Phospholamban R14del
Recruiting
- Phospholamban R14del Cardiomyopathy
- +2 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jul 23, 2021
Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)
Not yet recruiting
- Localized Osteosarcoma
- +3 more
- Cabozantinib S-malate
- +7 more
- (no location specified)
Jan 4, 2023
Phospholamban R14del Mutation-related Cardiomyopathy Trial in Netherlands (Eplerenone)
Completed
- Phospholamban R14del Mutation-related Cardiomyopathy
-
Sneek, Friesland, Netherlands
- +3 more
Oct 15, 2021
Enterococcal Bacteremia Trial in Spain (Short-treatment of any active antibiotic regimen 7 days of any active antibiotic
Recruiting
- Enterococcal Bacteremia
- Short-treatment of any active antibiotic regimen 7 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia.
- Long-treatment of any active antibiotic regimen 14 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia.
-
Coruña, A Coruña, Spain
- +21 more
Aug 10, 2022
NSCLC Trial in Worldwide (INC280 (capmatinib))
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- INC280 (capmatinib)
-
Long Beach, California
- +95 more
Dec 29, 2022
Bloodstream Infection Trial in Spain (Short-treatment of any active antibiotic regimen, Long-treatment of any active antibiotic
Recruiting
- Bloodstream Infection
- Short-treatment of any active antibiotic regimen
- Long-treatment of any active antibiotic regimen
-
Oviedo, Asturias, Spain
- +29 more
May 20, 2022
Metastatic Triple Negative Breast Cancer, Metastatic Colorectal Cancer Trial in Worldwide (Talimogene Laherparepvec,
Completed
- Metastatic Triple Negative Breast Cancer
- Metastatic Colorectal Cancer
- Talimogene Laherparepvec
- Atezolizumab
-
Los Angeles, California
- +16 more
Nov 22, 2022
Met Non Small Cell Cancer Registry (MOMENT)
Recruiting
- Cancer
-
Fort Lauderdale, Florida
- +53 more
Nov 3, 2022
Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)
Active, not recruiting
- Advanced Follicular Lymphoma
- Obinutuzumab
- +5 more
-
Boulder, Colorado
- +33 more
Nov 21, 2022
Herpes Zoster Trial in Worldwide (Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A), Placebo)
Active, not recruiting
- Herpes Zoster
- Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)
- Placebo
-
Tallinn, Estonia
- +43 more
Nov 14, 2022
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +4 more
-
Brasschaat, Belgium
- +53 more
Nov 29, 2022
Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60
Active, not recruiting
- Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
- epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
- +5 more
-
Candiolo, TO, Italy
- +14 more
Nov 15, 2021
Mature B-Cell Leukemia Burkitt Type, Burkitt Lymphoma (BL), Unclassifiable Lymphoma Between DCBL and BL Trial in Spain
Recruiting
- Mature B-Cell Leukemia Burkitt Type
- +2 more
- Rituximab
- +11 more
-
Badalona, Barcelona, Spain
- +28 more
Sep 17, 2021
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)
Completed
- Pneumococcal Infections
- V114
- +2 more
-
Palo Alto, California
- +51 more
Sep 23, 2022
Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin
Completed
- Refractory or Recurrent Solid Tumors
- +3 more
- Eribulin mesilate
- Irinotecan hydrochloride
-
Marseille, Bouches-du-Rhône, France
- +38 more
Jun 20, 2022
COVID-19, SARS-CoV 2, Convalescence Trial in Guadalajara, Hermosillo, Mexico City (convalescent plasma)
Unknown status
- COVID-19
- +4 more
- convalescent plasma
-
Guadalajara, Jalisco, Mexico
- +2 more
Jun 3, 2020
Hodgkin Lymphoma Trial in Italy, Poland, Spain (Nivolumab 10 MG/ML)
Recruiting
- Hodgkin Lymphoma
- Nivolumab 10 MG/ML
-
Pavia, P.le Golgi 19, Italy
- +26 more
Aug 11, 2021
Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)
Recruiting
- Glioblastoma
- Adult-type Diffuse Gliomas
-
Beverly Hills, California
- +83 more
Jul 25, 2022
Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)
Recruiting
- Respiratory Syncytial Virus
- Human Metapneumovirus
- mRNA-1345
- +3 more
-
Andalusia, Alabama
- +72 more
Feb 15, 2023
SARS-CoV-2 Infection, COVID-19, Maternal Immunization Trial in Worldwide (BNT162b2, Placebo)
Completed
- SARS-CoV-2 Infection
- +2 more
- BNT162b2
- Placebo
-
Birmingham, Alabama
- +85 more
Aug 22, 2022